Introduction
Vitamin Ds metabolites, among other important hormonal systems, regulate the feto-maternal calcium homeostasis during pregnancy [11, 22] . The three main metabolites are: 25-hydroxyvitamin Ds (25(OH)D3), which is formed in the liver by 25-hydroxylation of vitamin Da, and is the precursor for further hydroxylation in the kidneys to 24,25-dihydroxyvitamin Ds (24, 25 (OH)2D3) and to the hormonally most active form 1,25-dihydroxyvitamin Ds (1,25(OH) 2 D 3 ).
Our present knowledge of the human maternalfetal relationship of these metabolites is confined to studies in which these metabolites were investigated in humans by comparing post-partum maternal and cord sera levels [9, 10, 14, 15, 31] . As yet, there is not a unanimous agreement concerning the degrees and mechanisms of transplacental transfer from mother to fetus of each of the three metabolites [4, 21] . Moreover, the contribution of fetal metabolism to its own pool of the hydroxylated metabolites is still uncertain [11, 21] . A recent data shows that the fetus most probably contributes to its own 1,25(OH) 2 D3 pool [19] . The maternal and cord sera levels of these metabolites were not yet correlated with another important compartment -the amniotic fluid. In the past, we have determined amniotic fluid levels of 25(OH)D3 and 24,25(OH)2D3 during pregnancy [23] . However, the source of the amniotic fluid vitamin D3 metabolites remained unclear.
In the present study »levels of amniotic fluid 25(OH)D 3 , 24,25(OH) 2 D 3 and 1,25(OH) 2 D3 at term were compared with maternal and fetal cord serum levels. This information may be helpful in the assessment of the source of these metabolites in amniotic fluid.
Material and methods
Amniotic fluids, fetal cord and maternal blood samples were obtained from twenty-six normal pregnant white women during elective cesarean sections at 37 -40 weeks of pregnancy during the period of December 1982-April 1983. None of the women received vitamin D preparations during pregnancy. Fetal and maternal sera were separated by centrifugation. The amniotic fluids obtained were not contaminated by blood. They were centrifuged at 3 000 r. p. m. and the cell free supernatant was frozen. All the samples were stored at -40 °C until further work up. [7] with the addition of sodium molybdate [8] and kept lyophilized and refrigerated (-40 °C) until used.
To check for possible underestimations, controls were run in which known quantities of vitamin D 3 metabolites were added to serum samples. The assays of such controls resulted in good quantitative recoveries (88% for 25(OH)D 3 ; 89% for 24,25(OH) 2 D 3 ). A student's t-test was used to assess the statistical significance of the experimental data. Where needed, a student's t-test for unequal variance was used. For correlating the various variants, least squares correlation coefficients were calculated.
Results
The results are presented in table I. The amniotic fluid level of 25(OH)D 3 and 24,25(OH) 2 D 3 in this study are lower than those we have published previously and in agreement with the findings of LASEBNIK, et al. [20] (figures 1 and 2). Our data, at that time [23] were obtained by another assay method [13] which has since shown to produce higher than average results [26] . Amniotic fluid levels of 1,25(OH) 2 D 3 are shown in figure 3.
Fetal and maternal serum levels of the three vitamin D 3 metabolites were not statistically different. However, the differences between maternal serum and amniotic fluid levels of the Maternal serum 1,25(OH)2D3 levels were significantly higher (p < 0.04) at term (36.5 + 21.5 pg/ml; n = 17) as compared with those from normal controls (24.9 ±11.0 pg/ml; n = 31).
Comment
The source of amniotic fluid vitamin D 3 metabolites has yet to be established. Fetal urine is the major contributor of water, ions, steroids and other compounds to the amniotic fluid at term [3, 18] . Another source, quantitatively of lesser importance, is the chorionic plate of the placenta [1] . This route was shown to exist by the demonstration of a very rapid transfer into amniotic fluid of relatively large lipid soluble components such as meperidine (M. W. + 300) which occurs, most probably through the fetal side of the placenta from the fetal capillary bed [28] . The amniotic fluid is also constantly circulating through the fetal lungs which contribute some of the fluid's components [5] .
Data from normal adults show that urinary concentrations of 25(OH)D 3 and 1,25(OH) 2 D 3 are low compared with their serum levels [12] . Most of these urinary vitamin D 3 metabolites are glucoronidate conjugates [12, 25] . The levels of amniotic fluid vitamin D 3 metabolites reported in this study, however, were of unconjugated forms, similar to those in blood serum, and were considerably higher than the levels expected, should urinary excretion be their main source. Our finding of a good correlation between 25(OH)D 3 levels of maternal and fetal cord sera and no correlation of 1,25(OH)2D 3 levels in these sera is consistent with some similar reports [2, 14, 27] and inconsistent with others [10, 29] . We found also a good correlation between the fetal and maternal serum levels of 24,25(OH) 2 D 3 (r = 0.73; ρ < 0.01), which differs from the data of HILLMAN, et al. [15] and WEISMAN et al. [30] .
The mean cord serum levels of all three metabolites were somewhat lower than the respective maternal serum levels. Significantly lower concentrations of all three metabolites were found in the amniotic fluid as compared with the maternal serum levels. Similar differences were found between the concentration of 25(OH)D 3 and 24,25(OH) 2 D 3 of fetal cord serum and amniotic fluid. In contrast to the above, amniotic fluid 1,25(OH) 2 D 3 levels did not differ significantly from those of the fetal cord serum levels though their concentration was about half of that of the serum. This could perhaps suggest a higher transfer clearance of 1,25(OH) 2 D 3 from fetal chorionic plate capillaries into the amniotic fluid. However, no correlation was found between 1,25(OH) 2 D 3 in amniotic fluid and fetal cord serum. There was also no correlation between fetal serum levels of 24,25(OH) 2 D 3 and amniotic fluid levels of this metabolite. The lack of correlation between the levels of these dihydroxyvitamin D 3 metabolites in fetal serum and amniotic fluid may possibly be attributed either to some fetal metabolism following ingestion of the amniotic fluid or to different sources of these metabolites to fetal serum (i. e. from maternal circulation, fetal production and decidua [32]). Although direct transfer of these metabolites from the decidua through the amniotic membrane is unlikely [1] their contribution to the amniotic fluid by the decidua [32] cannot be excluded. In comparison, 25(OH)D 3 levels in maternal serum and fetal serum correlated well with their amniotic fluid levels (r = 0.697, ρ < 0.01 andr = 0.681, ρ < 0.01 respectively).
As the fetal liver is presumably incapable of performing the 25-hydroxylation of vitamin Da [11] the supply of this metabolite to the fetal serum and through the chorionic plate to the amniotic fluid is therefore most probably from only one source e. g. -maternal serum.
In conclusion: the findings in this study are consistant with the hypothesis that the main source of amniotic fluid vitamin Da metabolites is by a direct transfer from fetal serum through the chorionic plate of the placenta, the relative contribution of the decidua is yet to be studied. were not statistically different from the amniotic fluid levels, even though fetal cord serum levels were higher. In in vitro studies on the transplacental transfer of vitamin D 3 metabolites, this author has shown that placental clearance of 1,25(OH) 2 D 3 from maternal to fetal circulation is about ten folds higher than that of 25(OH)D 3 , presumably due to the differences in binding of these two metabolites by the serum. Our hypothesis is that transfer of vitamin D 3 metabolites into the amniotic fluid is mainly via the fetal serum through the chorionic plate of the placenta. If this hypothesis is valid, then the expected amniotic fluid levels of the above three metabolites compared to their fetal serum levels would be as found in this work, and in consistance with our previous findings on the in vitro transplacental transfer. 25-hydroxyvitamin D 3 was the only metabolite whose levels correlated significantly both between maternal serum levels and fetal serum levels with amniotic fluid levels (r = 0.697, p < 0.01 and r = 0.681, p < 0.01 respectively). We don't have a good explanation for this finding except to assume that it may give support to the supposition of GRAY, et al. that the fetal liver does not possess the ability of 25-hydroxylation of cholecalciferol, this maternal serum serves as the only constant source of 25(OH)D 3 enabling a steady state to be reached between the three compartments. 18.03 ± 10.8 ng/ml, 1.473 ± 1.562 ng/ml und 36.0 ± 21.5 pg/ml im maternalen Serum, im Nabelschnurblut 13.15 ± 8.3 ng/ml, 0.9 ± 0.76 ng/ml und 29.2 ± 18.55 pg/ml und im Fruchtwasser 0.732 ± 0.508 ng/ml, 0.121 ± 0.104 ng/ml und 14.3 ± 10.0 pg/ml. Bei den Konzentrationen der 3 Metabolite im mütterlichen Serum und in der Nabelschnur gab es keine statistisch signifikanten Unterschiede. Bezüglich des 25 3 , cet auteur a montre que la clearance placentaire de la 1,25(OH) 2 D 3 de la circulation maternelle vers la circulation foetale est environ 10 fois plus elevee que celle de la 25(OH)D 3 , vraissemblablement du fait des differences de liaison dans le serum de ces deux metabolites. Notre hypothese est que le transfert des metabolites de la vitamine D 3 vers le liquide amniotique s'effectue principalement par le serum foetal, ä travers le chorion placentaire. Si cette hypothese est valide, les taux attendus dans le liquide amniotique de ces trois metabolites, en comparaison des taux seriques foetaux, devraient etre ceux trouves dans ce travail, et concordants avec nos donnees anterieures concernant le transfert transplacentaire in vitro. La 25-hydroxyvitamine D 3 est le seul metabolite dont les taux sont correles significativement pour les taux maternels et pour les taux foetaux avec les taux du liquide amniotique (r = 0,697, p < 0,01 et r = 0,681, p < 0,01 respectivement). Nous n'avons pas de bonne explication pour ce fait sauf qu'on peut supposer qu'il peut appuyer la supposition de GRAY et col. que le foie foetal ne dispose pas de la capacite de 25-hydroxylation du cholecalciferol, ainsi le serum maternel servirait de seule source constante de 25(OH)D 3 en permettant d'atteindre un equilibre stable, entre les trois compartiments.
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